Clinical Trial Update: Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD [Phase 3]

View source ↗

Summary

Phase 3 trial comparing tiotropium inhalation solution (Respimat) with Spiriva HandiHaler in chronic obstructive pulmonary disease, assessing efficacy and safet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• SPIRIVA HANDIHALER (TIOTROPIUM BROMIDE)
• Tiotropium inhalation solution (Respimat inhaler) (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED